PAROXETINE
These highlights do not include all the information needed to use Paroxetine Extended-Release Tablets, USP safely and effectively. See full prescribing information for Paroxetine Extended-Release Tablets, USP. Paroxetine Extended-Release Tablets, USP for oral use Initial U.S. Approval: 1992
f562ab1a-adb9-4154-81cd-ceb480234331
HUMAN PRESCRIPTION DRUG LABEL
Jan 24, 2024
Rhodes Pharmaceuticals L.P.
DUNS: 831928986
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
PAROXETINE HYDROCHLORIDE HEMIHYDRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
PAROXETINE HYDROCHLORIDE HEMIHYDRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
PAROXETINE HYDROCHLORIDE HEMIHYDRATE
Product Details
FDA regulatory identification and product classification information